Ho Ching

Ho Ching is a Vice President at Temasek with a strong background in public and private healthcare investments. With experience in biotech research and a PhD in Biomedical Engineering from UCLA, Ho has a proven track record of developing innovative platforms for drug screening and DNA sequencing. Their expertise in nanoparticle-lipid bilayer interactions has been published in reputable journals. Ho...